Literature DB >> 23433998

Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment.

Toyomi Satoh1, Koji Matsumoto, Yumiko O Tanaka, Azusa Akiyama, Sari Nakao, Manabu Sakurai, Hiroyuki Ochi, Mamiko Onuki, Takeo Minaguchi, Hideyuki Sakurai, Hiroyuki Yoshikawa.   

Abstract

INTRODUCTION: Silent venous thromboembolism (VTE) often occurs before treatment in ovarian or endometrial cancer and management can decrease VTE after treatment. However, the incidence of VTE before treatment and the impact of management are still unclear in cervical cancer.
MATERIALS AND METHODS: We investigated the incidence of VTE before treatment in 272 consecutive patients with cervical cancer, and the impact of management on prevention of VTE during and after treatment. D-dimer levels before treatment were examined in all patients. Venous ultrasonography of the lower extremities was performed in patients with D-dimer ≥1.5μg/ml. Deep vein thrombosis (DVT) in the pelvis or abdomen was diagnosed by enhanced computed tomography.
RESULTS: Thirteen patients (4.8%; 3 preoperatively, 10 before radiotherapy or concurrent chemoradiotherapy) were diagnosed with DVT, although DVT was symptomatic in only 1 patient. None of the 13 patients showed pulmonary embolism on pulmonary scanning. Although 4 of 128 patients (3.1%) developed VTE after radical hysterectomy, none of the 124 patients who underwent radiotherapy or concurrent chemoradiotherapy developed VTE during or after treatment.
CONCLUSIONS: These data suggest that VTE before treatment occurs less frequently with cervical cancer than with ovarian or endometrial cancer. However, management may decrease VTE during and after treatment, especially radiotherapy.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23433998     DOI: 10.1016/j.thromres.2013.01.027

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  D-dimer as a potential clinical marker for predicting metastasis and progression in cancer.

Authors:  Hong Dai; Hongxing Zhou; Yingxin Sun; Zhe Xu; Shuo Wang; Tongbao Feng; Ping Zhang
Journal:  Biomed Rep       Date:  2018-09-14

Review 2.  A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology.

Authors:  Federico Romano; Giovanni Di Lorenzo; Guglielmo Stabile; Mariateresa Mirandola; Stefano Restaino; Patrizia Ianniello; Giuseppe Mirenda; Giuseppe Ricci
Journal:  Cancers (Basel)       Date:  2022-05-15       Impact factor: 6.575

3.  A risk score for prediction of venous thromboembolism in gynecologic cancer: The Thrombogyn score.

Authors:  Lucy A Norris; Mark P Ward; Sharon A O'Toole; Zibi Marchocki; Nadia Ibrahim; Ali S Khashan; Feras Abu Saadeh; Noreen Gleeson
Journal:  Res Pract Thromb Haemost       Date:  2020-05-28

4.  Incidence and risk factors of perioperative venous thromboembolism in patients with cervical cancer.

Authors:  Hongle Zhao; Yan Peng; Meng Lv; Yanmei Shi; Shuxiang Zhang
Journal:  Mol Clin Oncol       Date:  2022-05-09

5.  Analysis of risk factors for deep venous thrombosis in patients with gynecological malignant tumor: A clinical study.

Authors:  Qun Li; Yinling Xue; Yuan Peng; Lin Li
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

6.  Cancer cell-derived immunoglobulin G activates platelets by binding to platelet FcγRIIa.

Authors:  Shuo Miao; Dan Shu; Ying Zhu; Meng Lu; Qingsong Zhang; Youliang Pei; Ao-Di He; Rong Ma; Bixiang Zhang; Zhang-Yin Ming
Journal:  Cell Death Dis       Date:  2019-01-28       Impact factor: 8.469

7.  Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.

Authors:  Hirotsugu Kenmotsu; Akifumi Notsu; Keita Mori; Shota Omori; Takahiro Tsushima; Yasuomi Satake; Yoshihiro Miki; Masakazu Abe; Masahito Ogiku; Toshio Nakamura; Masakazu Takagi; Hideto Ochiai; Hirofumi Yasui; Toshiaki Takahashi
Journal:  Cancer Med       Date:  2021-01-09       Impact factor: 4.452

8.  High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.

Authors:  Manabu Sakurai; Toyomi Satoh; Koji Matsumoto; Hiroo Michikami; Yuko Nakamura; Sari Nakao; Hiroyuki Ochi; Mamiko Onuki; Takeo Minaguchi; Hiroyuki Yoshikawa
Journal:  Int J Gynecol Cancer       Date:  2015-05       Impact factor: 3.437

9.  Risk factors for venous thromboembolism induced by prolonged bed rest during interstitial brachytherapy for gynecological cancer: a retrospective study.

Authors:  Keiko Nemoto Murofushi; Tetsuya Tomita; Kayoko Ohnishi; Kei Nakai; Azusa Akiyama; Tsukasa Saida; Toshiyuki Okumura; Katsuyuki Karasawa; Toyomi Satoh; Hideyuki Sakurai
Journal:  Radiat Oncol       Date:  2021-06-29       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.